The percentages of strongly positive ezrin, ezrinThr-567 and ezrinTyr-353 cells were 40.7%, 45.3% and 48.0% in NSCLC, respectively, and were also significantly higher than in adjacent non-tumor tissues and normal tissue counterparts (P < 0.01). The gene discussed is EZR; the disease is non-small cell lung carcinoma.